相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Growth Curves for Children with X-linked Hypophosphatemia
Meng Mao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
X-Linked Hypophosphatemia: A New Era in Management
Kathryn Dahir et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck-Nielsen et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score
Tom D. Thacher et al.
BONE (2019)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
Michael P. Whyte et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Impaired mineral quality in dentin in X-linked hypophosphatemia
Benjamin R. Coyac et al.
CONNECTIVE TISSUE RESEARCH (2018)
Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale
Michael P. Whyte et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Rickets
Thomas O. Carpenter et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease
Jessica Connor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth
B. Salmon et al.
CONNECTIVE TISSUE RESEARCH (2014)
Therapeutic management of hypophosphatemic rickets from infancy to adulthood
Agnes Linglart et al.
ENDOCRINE CONNECTIONS (2014)
FGF-23 Regulates CYP27B1 Transcription in the Kidney and in Extra-Renal Tissues
Ankanee Chanakul et al.
PLOS ONE (2013)
Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia
Marc D. McKee et al.
PERIODONTOLOGY 2000 (2013)
Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment
Catherine Quinlan et al.
PEDIATRIC NEPHROLOGY (2012)
A Clinician's Guide to X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets
O Mäkitie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
